Literature DB >> 12870109

The edrophonium test.

Robert M Pascuzzi1.   

Abstract

Cholinesterase inhibitors (CEIs) have been known to improve strength in patients with myasthenia gravis (MG) since the 1930s, and have been used as a diagnostic test since the early 1950s. The following review summarizes the history of edrophonium usage in myasthenia gravis, reviews the literature with regard to the method of performing the edrophonium test, and discusses the available information regarding sensitivity and specificity of the test with respect to diagnosis of MG.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12870109     DOI: 10.1055/s-2003-40755

Source DB:  PubMed          Journal:  Semin Neurol        ISSN: 0271-8235            Impact factor:   3.420


  13 in total

Review 1.  Treatment of myasthenia gravis: focus on pyridostigmine.

Authors:  Lorenzo Maggi; Renato Mantegazza
Journal:  Clin Drug Investig       Date:  2011-10-01       Impact factor: 2.859

2.  Dysphonia as first symptom of late-onset myasthenia gravis.

Authors:  Manuel Montero-Odasso
Journal:  J Gen Intern Med       Date:  2006-06       Impact factor: 5.128

3.  Alterations of serum cholinesterase in patients with gastric cancer.

Authors:  Shan-Zhi Gu; Xin-Han Zhao; Ping Quan; Sheng-Bin Li; Bo-Rong Pan
Journal:  World J Gastroenterol       Date:  2005-08-07       Impact factor: 5.742

4.  Myasthenia Gravis Presenting as Persistent Unilateral Ptosis with Facial Droop.

Authors:  Sean K Golden; Chris J Reiff; Chris J Painter; Michael D Repplinger
Journal:  J Emerg Med       Date:  2015-03-19       Impact factor: 1.484

5.  Intermittent weakness and mediastinal weakening.

Authors:  Umer Feroze Malik; Mersadies R Martin; Hien D Pham; Ahmed Mahmoud; Sheela Kapre
Journal:  Mcgill J Med       Date:  2009-11-16

6.  Fiberoptic endoscopic evaluation of swallowing with simultaneous Tensilon application in diagnosis and therapy of myasthenia gravis.

Authors:  Tobias Warnecke; Inga Teismann; Julian Zimmermann; Stephan Oelenberg; E Bernd Ringelstein; Rainer Dziewas
Journal:  J Neurol       Date:  2008-01-28       Impact factor: 4.849

Review 7.  Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity.

Authors:  Matthew N Meriggioli; Donald B Sanders
Journal:  Lancet Neurol       Date:  2009-05       Impact factor: 44.182

8.  Myasthenia gravis: a review.

Authors:  Annapurni Jayam Trouth; Alok Dabi; Noha Solieman; Mohankumar Kurukumbi; Janaki Kalyanam
Journal:  Autoimmune Dis       Date:  2012-10-31

9.  Thymoma in myasthenia gravis: from diagnosis to treatment.

Authors:  Fredrik Romi
Journal:  Autoimmune Dis       Date:  2011-08-10

10.  Edrophonium Challenge Test for Blepharospasm.

Authors:  Shinichi Matsumoto; Nagahisa Murakami; Hidetaka Koizumi; Masatoshi Takahashi; Yuishin Izumi; Ryuji Kaji
Journal:  Front Neurosci       Date:  2016-06-06       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.